According to a recent study, dupilumab successfully decreases immunoglobulin E (IgE) serum levels in atopic dermatitis (AD) patients regardless of dosing interval.
Maternal high protein diet linked to AD during first year of life
According to a new study, a maternal high protein diet may be a risk factor for infantile atopic dermatitis (AD) during the first year of life.
QoL impairment and worse symptoms in PsO, AD linked to differing views on disease severity
According to a new study, psoriasis and atopic dermatitis (AD) patients may have differing views on disease severity, a phenomenon known as discordant severity grading. This phenomenon has been linked to higher symptom expression and greater quality of life (QoL) impairment.
Dupilumab shows rapid improvement in AD severity for pediatric patients
According to a new study, dupilumab has been shown to reduce severity and improve quality of life (QoL) in pediatric patients with atopic dermatitis (AD) two weeks after treatment.
New study shows probiotic has positive effect on pediatric AD patients
According to a new study, a single-strain probiotic was found to have a positive effect on atopic dermatitis (AD) in pediatric patients.
New study shows AD is associated with decreased school performance
According to a new study, adolescents with atopic dermatitis (AD) are more likely to have their school work adversely affected by their skin condition.
Air pollutant exposure, particulate matter linked to more medical visits for AD patients
Air pollution and particulate matter are associated with more medical visits for patients with atopic dermatitis (AD), according to a new study.
Online mindfulness training shows improvement in QoL, severity for AD patients
Online mindfulness training has shown improvements in patient quality of life (QoL) and disease severity in Atopic Dermatitis (AD), according to a new study.
Patients, caregivers similarly rate important factors in eczema clinical trial participation
According to a new study, patients and caregivers similarly ranked the importance of factors when choosing whether to participate in eczema clinical trials.
AD linked to higher risk of osteoarthritis
According to a recent study, individuals with atopic dermatitis (AD) and asthma may be more likely to develop osteoarthritis.
